The intravenous equipment market was valued for $15.0 billion in 2022 and is estimated to reach $26.7 billion by 2032, exhibiting a CAGR of 5.9% from 2023 to 2032.
Intravenous (IV) equipment refers to the tools and devices used in intravenous therapy, a medical procedure that involves delivering fluids, medications, or nutrients directly into a patient's bloodstream through a vein. IV therapy is commonly used for various purposes, including hydration, administering medications, blood transfusions and nutritional support. Examples of intravenous equipment include needles or catheters that are inserted into a vein to create access, flexible tubing’s that connects the IV bag or container to the patient and infusion pumps are electronic devices that control and regulate the flow rate, ensuring precise delivery.
The major factors driving the growth of the intravenous equipment market are the increase in number of people suffering from chronic conditions, rise in geriatric population, and continuous advancements in IV equipment technology. The demand for IV therapy is driven by the rising incidence of chronic diseases such cancer, diabetes, cardiovascular problems, and infectious diseases. Intravenous administration allows for the direct and efficient delivery of medications, fluids and nutrition, making it a crucial treatment method for patients with chronic conditions. In addition, world's population is experiencing a significant demographic shift, with a rapidly growing elderly population. The elderly people are more prone to developing chronic illnesses, which necessitate frequent hospital stays and medical treatment. IV therapy plays a vital role in providing supportive care to geriatric patients. Thus, the increasing geriatric population is contributing to the growth of the intravenous equipment market.
Further, continuous advancements in intravenous equipment technology have improved safety, precision and ease of use in administering intravenous therapy. Innovations such as smart infusion pumps, integrated connectivity solutions and needleless IV systems have enhanced the efficiency and accuracy of drug delivery, reduced the risk of medication errors and improved patient outcomes. Furthermore, growing awareness about the benefits of intravenous therapy, such as faster drug absorption, precise medication delivery and improved patient compliance, has increased among healthcare professionals and patients. Thus, more medical practitioners are incorporating IV therapy into their treatment plans, leading to a higher demand for intravenous equipment.
Additionally, as many nations invest more funds in enhancing healthcare infrastructure and boosting access to high-quality medical services, healthcare spending keeps rising. This increased healthcare spending encompasses the procurement of essential medical equipment, including IV equipment, to meet the growing demand for advanced patient care, thereby propelling the market growth. In addition, emergency departments and critical care units frequently rely on IV therapy to stabilize patients quickly and administer life-saving medications or fluids. The rising number of emergency care cases and trauma incidents worldwide has significantly contributed to the demand for IV equipment in these settings. IV equipment plays a vital role in delivering essential treatments promptly and efficiently, ensuring optimal patient outcomes in critical care scenarios.
The intravenous equipment market is segmented into product type, end user, and region. On the basis of product type, the market is categorized into IV catheters, infusion pumps, administration sets, needleless connectors, and others. Further, administration sets are classified into solution administration sets and blood administration sets. On the basis of end user, the market is segregated into hospital and clinics, homecare settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global intravenous equipment market are Becton, Dickinson and Company, B. Braun SE, ICU Medical, Inc., vygon, Baxter International Inc., Teleflex Incorporated., 3M Company, AngioDynamics, Inc., Terumo Corporation and Poly Medicure Ltd. The key players have adopted strategy such as product approval and acquisition to expand their product portfolio.
Intravenous (IV) equipment refers to the tools and devices used in intravenous therapy, a medical procedure that involves delivering fluids, medications, or nutrients directly into a patient's bloodstream through a vein. IV therapy is commonly used for various purposes, including hydration, administering medications, blood transfusions and nutritional support. Examples of intravenous equipment include needles or catheters that are inserted into a vein to create access, flexible tubing’s that connects the IV bag or container to the patient and infusion pumps are electronic devices that control and regulate the flow rate, ensuring precise delivery.
The major factors driving the growth of the intravenous equipment market are the increase in number of people suffering from chronic conditions, rise in geriatric population, and continuous advancements in IV equipment technology. The demand for IV therapy is driven by the rising incidence of chronic diseases such cancer, diabetes, cardiovascular problems, and infectious diseases. Intravenous administration allows for the direct and efficient delivery of medications, fluids and nutrition, making it a crucial treatment method for patients with chronic conditions. In addition, world's population is experiencing a significant demographic shift, with a rapidly growing elderly population. The elderly people are more prone to developing chronic illnesses, which necessitate frequent hospital stays and medical treatment. IV therapy plays a vital role in providing supportive care to geriatric patients. Thus, the increasing geriatric population is contributing to the growth of the intravenous equipment market.
Further, continuous advancements in intravenous equipment technology have improved safety, precision and ease of use in administering intravenous therapy. Innovations such as smart infusion pumps, integrated connectivity solutions and needleless IV systems have enhanced the efficiency and accuracy of drug delivery, reduced the risk of medication errors and improved patient outcomes. Furthermore, growing awareness about the benefits of intravenous therapy, such as faster drug absorption, precise medication delivery and improved patient compliance, has increased among healthcare professionals and patients. Thus, more medical practitioners are incorporating IV therapy into their treatment plans, leading to a higher demand for intravenous equipment.
Additionally, as many nations invest more funds in enhancing healthcare infrastructure and boosting access to high-quality medical services, healthcare spending keeps rising. This increased healthcare spending encompasses the procurement of essential medical equipment, including IV equipment, to meet the growing demand for advanced patient care, thereby propelling the market growth. In addition, emergency departments and critical care units frequently rely on IV therapy to stabilize patients quickly and administer life-saving medications or fluids. The rising number of emergency care cases and trauma incidents worldwide has significantly contributed to the demand for IV equipment in these settings. IV equipment plays a vital role in delivering essential treatments promptly and efficiently, ensuring optimal patient outcomes in critical care scenarios.
The intravenous equipment market is segmented into product type, end user, and region. On the basis of product type, the market is categorized into IV catheters, infusion pumps, administration sets, needleless connectors, and others. Further, administration sets are classified into solution administration sets and blood administration sets. On the basis of end user, the market is segregated into hospital and clinics, homecare settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global intravenous equipment market are Becton, Dickinson and Company, B. Braun SE, ICU Medical, Inc., vygon, Baxter International Inc., Teleflex Incorporated., 3M Company, AngioDynamics, Inc., Terumo Corporation and Poly Medicure Ltd. The key players have adopted strategy such as product approval and acquisition to expand their product portfolio.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intravenous equipment market analysis from 2022 to 2032 to identify the prevailing intravenous equipment market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the intravenous equipment market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global intravenous equipment market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly update (only available with the purchase of an enterprise license)
- 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
- Free updated version (once released) with the purchase of a 1-5 or enterprise user license.
- 16 analyst hours of support (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% free customization (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
- Free data pack (Excel version) with the purchase of a 1-5 or enterprise user license.
- Free report update, if the report is 6-12 months old or older.
- 24-hour priority response
- Free industry updates and white papers.
Key Market Segments
By Product Type
- IV catheters
- Infusion pumps
- Administration sets
- Type of set
- Solution administration sets
- Blood administration sets.
- Needleless connectors
- Others
By End User
- Hospitals and clinics
- Homecare settings
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- AngioDynamics, Inc.
- Becton, Dickinson and Company
- Vygon
- 3M Company
- Terumo Corporation
- Poly Medicure Ltd.
- B. Braun SE
- ICU Medical, Inc.
- Baxter International Inc.
- Teleflex Incorporated.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE
CHAPTER 5: INTRAVENOUS EQUIPMENT MARKET, BY END USER
CHAPTER 6: INTRAVENOUS EQUIPMENT MARKET, BY REGION
CHAPTER 7: COMPETITIVE LANDSCAPE
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to this report, the intravenous equipment market was valued at $15.0 billion in 2022, and is estimated to reach $26.7 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032.Intravenous equipment refers to a range of medical devices and accessories used in the administration of fluids, medications, and other treatments directly into a patient's bloodstream through a vein. This equipment is designed to ensure the safe, accurate, and controlled delivery of substances intravenously. Intravenous administration offers advantages such as rapid onset of action, accurate dosage control, and direct delivery to the bloodstream. As a result, there is a growing need for advanced intravenous equipment that can safely and efficiently deliver these drugs.
Key factors driving the growth of the intravenous equipment market are rising prevalence of chronic conditions, rise in geriatric population and increase in surgical procedures. Chronic diseases such as diabetes, cancer and renal diseases, are on the rise globally. These conditions often require long-term management and treatment, leading to an increased demand for intravenous therapies. For instance, cancer patients require continuous IV chemotherapy, thereby driving the demand for intravenous equipment. The rising incidence of these diseases is a significant driver of the intravenous equipment market. In addition, world's population is aging rapidly, particularly in developed countries. With age, the risk of chronic diseases and medical conditions increases. Elderly individuals often require hospitalization and continuous medical support, leading to a higher need for intravenous therapies. The aging population is thus contributing to the growth of the intravenous equipment market. In addition, increasing number of surgical procedures being performed globally has led to a higher demand for intravenous equipment in operating rooms and post-operative care units. IV fluids and medications are commonly used during surgical interventions to maintain patient hydration, provide anesthesia, and manage pain. As surgical volumes increase, so does the requirement for IV equipment.
Further, technological advancements have significantly improved the safety and efficiency of IV administration. For instance, the development of smart infusion pumps with dose error reduction systems (DERS) has minimized the risk of medication errors. Additionally, the integration of wireless communication with IV devices has streamlined workflow, enabling real-time monitoring and automated documentation. These innovations are driving the adoption of advanced IV equipment in healthcare settings. In addition, needleless connectors offer quick and convenient access to IV lines or ports, improving the efficiency of IV therapy. Healthcare providers can easily connect or disconnect syringes or IV tubing without the need for needle punctures. This streamlined process saves time and reduces the risk of accidental needlestick injuries among healthcare workers. Further, to speeding up medication administration, needleless connectors also facilitate the administration of intermittent medications or flushes. The ability to access the IV line without removing the dressing or disrupting the catheter site simplifies the process, enhancing patient comfort and reducing the likelihood of dressing-related complications.
Furthermore, there is a growing trend of shifting healthcare services from hospitals to home settings, driven by cost-effectiveness and patient preference. Home healthcare allows patients to receive treatments comfortably in their homes while reducing the burden on hospitals. Intravenous therapies are increasingly being administered in home settings, and the demand for portable and easy to use IV equipment has risen accordingly. Intravenous therapies are increasingly being administered in home settings for conditions such as chronic pain management, parenteral nutrition, and certain chemotherapy treatments. Portable and easy-to-use IV equipment is in high demand to facilitate home-based treatments effectively. Moreover, rapidly developing healthcare infrastructure in emerging economies has boosted the demand for intravenous equipment. Governments and private healthcare providers are investing heavily in improving medical facilities and expanding access to quality healthcare services. This, coupled with the rising disposable income and healthcare awareness, is driving the adoption of advanced IV equipment in these regions.
The intravenous equipment market is segmented into product type, end user, and region. On the basis of product type, the market is categorized into IV catheters, infusion pumps, administration sets, needleless connectors and others. Further, administration sets are classified into solution administration sets and blood administration sets. On the basis of end user, the market is segregated into hospital and clinics, homecare settings and others. Region wise, the market is analyzed across North America (the U. S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). The key players profiled in the study include Gilead Sciences, Inc., Becton, Dickinson and Company, B. Braun SE, ICU Medical, Inc., vygon, Baxter International Inc., Teleflex Incorporated., 3M Company, AngioDynamics, Inc., Terumo Corporation and Poly Medicure Ltd. The key players have adopted strategies such as acquisition and product approval to expand their product portfolio.
Key Market Insights
By product type, the IV catheters segment accounted for largest share in terms of revenue in 2022, and is expected to register highest CAGR during the forecast period.On the basis of end user, the hospitals and clinics segment accounted for largest share in terms of revenue in 2022. On the other hand, homecare settings segment is anticipated to register highest CAGR during the forecast period.
Region wise, North America occupied the largest share in terms of revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- AngioDynamics, Inc.
- Becton, Dickinson and Company
- Vygon
- 3M Company
- Terumo Corporation
- Poly Medicure Ltd.
- B. Braun SE
- ICU Medical, Inc.
- Baxter International Inc.
- Teleflex Incorporated.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
